-
公开(公告)号:US12084693B2
公开(公告)日:2024-09-10
申请号:US17055523
申请日:2019-05-15
Applicant: SPARK THERAPEUTICS, INC.
Inventor: Xavier Anguela , Sean Armour , Jayme Nordin
CPC classification number: C12N9/2408 , A61K48/005 , C12N15/86 , C12Y302/0102 , C12N2750/14143 , C12N2750/14152 , C12N2800/22 , C12N2830/001 , C12N2830/50
Abstract: The invention provides nucleic acids encoding acid α-glucosidase (GAA). In certain embodiments, nucleic acids have greater than about 86% sequence identity to a sequence selected from the group consisting of any of the sequences set forth as SEQ ID NOs:1-5. In certain embodiments, nucleic acids encoding acid α-glucosidase (GAA) contain less than 127 CpG dinucleotides. Expression cassettes, vectors, cells and cell lines and methods of using such nucleic acids encoding acid α-glucosidase (GAA) are also provided.
-
公开(公告)号:US20250101396A1
公开(公告)日:2025-03-27
申请号:US18828493
申请日:2024-09-09
Applicant: Spark Therapeutics, Inc.
Inventor: Xavier Anguela , Sean Armour , Jayme Nordin
Abstract: The invention provides nucleic acids encoding acid α-glucosidase (GAA). In certain embodiments, nucleic acids have greater than about 86% sequence identity to a sequence selected from the group consisting of any of the sequences set forth as SEQ ID NOs: 1-5. In certain embodiments, nucleic acids encoding acid α-glucosidase (GAA) contain less than 127 CpG dinucleotides. Expression cassettes, vectors, cells and cell lines and methods of using such nucleic acids encoding acid α-glucosidase (GAA) are also provided.
-